Published: Jul, 2018

With the massive rise in the hospitals across the globe, pharmaceutical companies can expect a promising rise in growth opportunities in the hospital pharmaceutical sector, observes Transparency Market Research in a recent report. The level of competition is rising as a number of leading pharmaceutical companies are venturing into the field of oncology, which is presently one of the most lucrative therapeutic segments in the hospital pharmaceuticals market.

Some of the leading companies in the market are Sanofi, Bristol-Myers Squibb, Roche, Merck, GlaxoSmithKline, and AstraZeneca.

According to the report, as economic slowdown and looming patent expiration of a number of blockbuster drugs shadow its growth prospects, the global hospital pharmaceuticals market will exhibit a moderate 3.9% CAGR over the period between 2015 and 2023. At this pace, the market is expected to rise to a valuation of US$280.3 bn by 2023.

hospital-pharmaceuticals-marketDemand for Cancer Therapeutics to Remain High

According to WHO data, cardiovascular diseases are responsible for nearly 31% of the world’s deaths annually. Thus the volume of therapeutic as well as diagnostics products dispensed by hospital pharmacies for cardiovascular diseases is high. However, owing to a high level of saturation in the market, the segment of cardiovascular diseases is likely to register a lower CAGR as compared to other indications over the report’s forecast period. The segment of oncology, on the other hand, is expected to witness a massive rise in valuation owing to the mounting number of cancer cases diagnosed every year globally. Geographically, the market in North America is likely to maintain its dominance, exhibiting a CAGR of 3.4% over the report’s forecast period.

Rising Prevalence of Chronic Diseases to Boost the Demand for Hospital Pharmaceuticals

Some of the key factors working in favor of the global hospital pharmaceuticals market are the vast rise in prevalence of chronic diseases such as cancer, diabetes, and a number of cardiovascular conditions and the rising expenditure on healthcare across emerging economies. The market is also expected to flourish in the face of rising prevalence of parasitic infections, which has bolstered the demand for anti-parasitic drugs in hospitals. The mounting rise in numbers of cancer patients is also pushing the market ahead and is expected to continue to remain a key driving factor for the market over the forecast period.

Besides these factors, the market will benefit from a steady rise in awareness regarding diseases, increased focus of pharmaceutical companies on the development of experimental drugs for rare diseases, and the vast rise in the number of specialty clinics and hospitals globally. In developed countries such as the U.S. and U.K., purchase of pharmaceutical drugs and other products in hospitals is driven by government policies that aim at assuring that hospitals get a fair share of profits from government procurement policies. The market in these countries is expected to remain lucrative over the forecast period as well.

This analysis of the global hospital pharmaceutical market is based on a recent report by Transparency Market Research, titled “Hospital Pharmaceuticals Market (Therapeutic Class - Cardiology, Oncology, nephrology and Urology, Neurology, Pain, and Infection; Indication - Cardiology, Oncology, nephrology and Urology, Neurology, Pain, and Infection; Geography - North America, Europe, Asia Pacific, Latin America, and Rest of the World) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2015 – 2023.”

For the study, the market has been segmented as follows:

Global Hospital Pharmaceuticals Market, by Therapeutic Class

  • Cardiology
    • Anti-hypertensives
    • Dyslipidemia drugs
    • Others
  • Oncology
    • Alkylating Agents
    • Anti-metabolites
    • Hormonal Agents
    • Immunomodulating Agents
    • Miscellaneous Drugs
  • Nephrology and Urology
    • Diuretic Agents
    • Anti-hypertensive Agents
    • Phosphate Binders
    • Anticholinergic Drugs
    • 5-Alpha Reductase Inhibitors
  • Neurology
    • Anti-anxiety Agents
    • Anti-migraine Drugs
    • Antidepressant Drugs
    • Anti-psychotic Drugs
  • Pain
    • Anticonvulsant Drugs
    • Anesthetic Drugs
    • Non-steroidal Anti-Inflammatory Drugs (NSAIDs)
    • Opioids
    • Non-narcotics Analgesic Drugs
  • Infection
    • Antibacterial Drugs
    • Antiviral Drugs
    • Antifungal Drugs
    • Antiparasite Drugs

Global Hospital Pharmaceuticals Market, by Indication

  • Cardiology
    • Coronary Heart Diseases
    • Stroke
    • High Blood Pressure
    • Heart Failure
    • Others
  • Oncology
    • Lung Cancer
    • Breast Cancer
    • Colorectal Cancer
    • Prostate Cancer
    • Others
  • Nephrology and Urology
    • Acute Kidney Failure
    • Chronic Kidney Diseases
    • Glomerular Diseases
    • Diabetes
    • Others
  • Neurology
    • Epilepsy
    • Alzheimer’s Disease
    • Parkinson’s Disease
    • Multiple Sclerosis
    • Others
  • Pain
    • Neuropathic Pain
    • Fibromyalgia
    • Osteoarthritis
    • Rheumatoid Arthritis
    • Cancer Pain
  • Infection
    • Tuberculosis
    • Pneumonia
    • Hepatitis A
    • Hepatitis B
    • Candida Infection
    • Fungal Meningitis
    • Shigellosis
    • Amoebiasis
    • Other

Global Hospital Pharmaceuticals Market, by Geography

  • North America
    • U.S.
    • Canada
  • Asia Pacific
    • China
    • Japan
    • Rest of APAC
  • Europe
    • U.K.
    • Germany
    • Rest of Europe
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Rest of the World

About Us:

Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.

Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through adhoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.

TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.

Contact

Transparency Market Research

90 State Street, Suite 700

Albany, NY 12207

Tel: +1-518-618-1030

USA - Canada Toll Free: 866-552-3453

Email: sales@transparencymarketresearch.com

Website: https://www.transparencymarketresearch.com

.